Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatitis B Virus Studies, and Cancer Immunotherapy and Biomarkers.
Efficacy and safety of acupuncture therapies for adult patients with mild and moderate major depressive disorder: A systematic review and meta-analysis
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey
Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of <i>ATRX</i> -Mutant Cancers to WEE1 Inhibition
Oncogenic Kinase–Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem–like Cells
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma
STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.
PubMed 2015cited by 12position: last
A tagging ALOX5AP polymorphism and risk of ischemic stroke in a northeastern Chinese Han population.
PubMed 2015cited by 6position: middle
The relationship between PPARγ gene and atherosclerotic cerebral infarction
Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species